ArticleNeuropsychiatric disease and treatment2016
Medication management during electroconvulsant therapy.
Article in Neuropsychiatric disease and treatment, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05308056 (Depth of Anetshesia During Electroconvulsive Therapy), which is not on this map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Depth of Anetshesia During Electroconvulsive Therapy
Who cites it
15 citing papers in PubMed.
- [Efficacy and safety of super electroconvulsive therapy for treatment-resistant depression: a retrospective analysis of 292 cases].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026Article
- Efficacy and safety of intravenously applied caffeine augmentation in electroconvulsive therapy.Neuroscience applied · 2025Article
- Variables associated with clinical outcomes and switching from unilateral to bitemporal electroconvulsive therapy: a retrospective study.Frontiers in psychiatry · 2025Article
- Electroconvulsive therapy in the Fourth Industrial Revolution (Review).Biomedical reports · 2024Review
- Seizure Duration and Electroconvulsive Therapy in Major Depressive Disorder.JAMA network open · 2024Article
- Pharmacologic management of adolescent catatonia: A dual-case series.The mental health clinician · 2024Article
- Use of ECT in Autism Spectrum Disorder and/or Intellectual Disability: A Single Site Retrospective Analysis.Journal of autism and developmental disorders · 2024Article
- Ketamine or ECT? What Have We Learned From the KetECT and ELEKT-D Trials?The international journal of neuropsychopharmacology · 2024Article
- Factors Predicting Ictal Quality in Bilateral Electroconvulsive Therapy Sessions.Brain sciences · 2021Article
- Case report: delayed response after electroconvulsive therapy in a patient with major depressive disorder.BMC psychiatry · 2021Article
- Successful bilateral electroconvulsive therapy in a patient with a seizure disorder taking levetiracetam, lorazepam, and zonisamide: A case report.The mental health clinician · 2021Article
- Use of Nitrous Oxide to Facilitate Induction for Electroconvulsive Therapy: A Case Report.The American journal of case reports · 2020Article
- The Efficacy and Safety of Concomitant Psychotropic Medication and Electroconvulsive Therapy (ECT).CNS drugs · 2020Review
- The impact of electroconvulsive therapy on the spatial QRS-T angle and cardiac troponin T concentration in psychiatric patients.PloS one · 2019Article
- General Anaesthesia Protocols for Patients Undergoing Electroconvulsive Therapy: Retrospective analysis of 504 sessions over a five-year period at a tertiary care hospital in Oman.Sultan Qaboos University medical journal · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electroconvulsive therapy (ECT) has demonstrated to be highly effective and safe, even life saving for many psychiatric disorders such as major depression, bipolar disorder and schizophrenia. Most patients who require ECT are also on concurrent pharmacotherapy. As such, the objective of this article is to provide a review of the most recent literature focusing on the medications used during an ECT procedure and on the effects of concurrent psychiatric and non-psychiatric medications on the effectiveness and safety of ECT. The review also attempts to summarize the recommendations derived from existing documents to guide pharmacotherapy decisions for patients undergoing ECT. For this purpose, using electronic databases, an extensive search of the current literature was made using ECT and medications or drug classes as keywords.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.